Search clinical trials for: ALA

Total 255755 results

Eli Lilly and Company

Completed

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)

Severe Sepsis

United States, Belgium, Spain, France, Finland, Germany, Canada, United Kingdom, Puerto Rico
Gilead Sciences

Completed

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

France, Moldova, Republic of, Romania, Russian Federation
Lee's Pharmaceutical Limited

Not yet recruiting

Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA）

5-aminolevulinic Acid | Fluorescence-guided Resection

China
Joint Authority for Päijät-Häme Social and Health...
Tampere University; Tampere University Hospital; Päijänne Tavastia Central Hospital and other collaborators

Completed

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Actinic Keratosis | Natural Daylight Photodynamic Therapy

Finland
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Hemodialysis Dependent Chronic Kidney Disease

Japan
Alios Biopharma Inc.

Withdrawn

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

Hepatitis B, Chronic
Yao Xie

Unknown

The Changes of CD4+T Cells Frequency and Function During Antiviral Therapy

Chronic Hepatitis B Infection

China
Merck Sharp & Dohme LLC

Completed

High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)

Melanoma
University Medical Centre Ljubljana

Recruiting

Platelet Agregation in Patients on ECMO

Platelet Refractoriness

Slovenia
Fu Jen Catholic University

Recruiting

Vegan Diet, Amla Fruits and Uric Acid

Hyperuricemia | Diet, Healthy | Cardiometabolic Syndrome

Taiwan
GlaxoSmithKline

Active, not recruiting

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Neoplasms

Spain, Netherlands, United States, Japan, France, Australia, Korea, Republic of, Canada
CRG UZ Brussel

Completed

Double Pick up in Poor Prognosis Women (DUOPICK)

Fertility Disorders

Belgium
SOTIO Biotech AG

Active, not recruiting

A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer

Colorectal Cancer

France, Spain, Belgium
Rush University Medical Center

Completed

Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty

Prosthesis-Related Infections

United States
Alexandria University

Completed

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Optic Atrophy

Egypt
Instituto Bernabeu

Completed

Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor (TAIL)

Ovarian Stimulation

Spain
University of Washington
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) (PENUT)

Extreme Prematurity

United States
Alnylam Pharmaceuticals

Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria Type 1 (PH1)

France, United Kingdom, Netherlands, Israel, Germany
DSM Nutritional Products, Inc.
SynteractHCR

Completed

Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants

Healthy Infants

Spain
University of Washington

Completed

Web-Based Treatment of Heavy Drinking Among Women With a History of Sexual Trauma

Heavy Drinking | Sexual Assault

United States
Bundang CHA Hospital
LG Life Sciences

Completed

Erythropoietin Therapy for Children With Cerebral Palsy

Cerebral Palsy

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Anemia

Italy
Novo Nordisk A/S

Completed

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (ONE)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Saudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
Institute of Liver and Biliary Sciences, India

Completed

Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).

Acute Liver Failure | Acute on Chronic Liver Failure

India
University of Wisconsin, Madison
Bunge Loders Croklaan

Completed

Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children

Overweight

United States
University of California, Irvine
Pomegranate Health; Jarrow Pharmaceuticals

Unknown

Study of the Effects of Pomegranate Tablets on Enlarged Prostates

Benign Prostatic Hyperplasia

United States
Aarhus University Hospital

Completed

Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

Insulin Sensitivity

Denmark
Chakshu Research, Inc.

Unknown

An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

Asteroid Hyalosis

United States
Amgen

Completed

Aranesp® Monthly Preference Study - 2

Kidney Disease
Beijing Ditan Hospital

Unknown

The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy

Chronic Hepatitis B Infection

China
Omicron Pharmaceuticals

Completed

Trial of Screening for ALOA-IgG AtheroAbzyme Test (OP512011)

Myocardial Ischemia | Acute Coronary Syndrome

Lebanon
University Medical Center Groningen

Recruiting

IL-2 PET Imaging in Advanced Solid Tumours

Metastatic Solid Tumor

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Non-dialysis Dependent Chronic Kidney Disease

Japan
OncoImmune, Inc.
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001)

Healthy Volunteers

United States
Shahid Beheshti University of Medical Sciences

Enrolling by invitation

The Effect of Erythropoietin in the Treatment of Scleral Necrosis

Conjunctival and Scleral Avascular Lesions

Iran, Islamic Republic of
University Hospital, Ghent
CEVAC Core Lab, University Ghent; Max Planck Institute for Infection Biology... and other collaborators

Completed

Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults

Prevention of Influenza

Belgium
Fondation Ophtalmologique Adolphe de Rothschild
University Hospital, Strasbourg, France; Centre Hospitalier Régional Metz-Thionville

Terminated

Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) (COVIDORNASE)

COVID-19 | Acute Respiratory Distress Syndrome

France
Hoffmann-La Roche

Terminated

Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD

Muscular Dystrophy (DMD)

United States, Canada
Janssen Research & Development, LLC

Terminated

A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus

Respiratory Syncytial Viruses

United States, Belgium, Canada, Hungary, Japan, Poland
Pfizer

Completed

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Hemophilia A

United States, Argentina, Austria, Colombia, Croatia, Jordan, Mexico, New Zealand, Oman, Peru, Poland, Romania, Turkey
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion

Symptomatic Focal Vitreomacular Adhesion

United States
Janssen Research & Development, LLC

Withdrawn

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus (STEP)

Metapneumovirus

Netherlands, United States, France, Taiwan, Korea, Republic of, Australia, Japan, Spain, Malaysia, Russian Federation, Sweden, Poland, Bulgaria, Argentina, Brazil, Ukraine
Kissei Pharmaceutical Co., Ltd.

Terminated

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Bundang CHA Hospital

Completed

Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy

Cerebral Palsy
FibroGen

Completed

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

Anemia

China
Hoffmann-La Roche

Completed

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

Anemia, Kidney Transplantation

Germany
North Texas Veterans Healthcare System

Completed

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

Acute Kidney Injury

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment

Chronic Renal Failure

United States
Novo Nordisk A/S

Completed

PROPACT: Retrospective Prophylaxis Patient Case Collection (PROPACT)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Slovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
Altor BioScience
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Sepsis | Acute Respiratory Distress Syndrome | Acute Lung Injury

United States

Search clinical trials for: ALA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations